Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Hutchmed (China)
HCM
5
Constellation Brands
STZ
US Stock MarketDetailed Quotes
ESPR Esperion Therapeutics
- 0.9005
- -0.0195-2.12%
Trading Apr 28 12:27 ET
178.43MMarket Cap-3.22P/E (TTM)
0.9626High0.8890Low1.57MVolume0.9400Open0.9200Pre Close1.45MTurnover0.80%Turnover RatioLossP/E (Static)198.15MShares3.940052wk High-0.46P/B176.46MFloat Cap0.819152wk Low--Dividend TTM195.96MShs Float120.9600Historical High--Div YieldTTM8.00%Amplitude0.7000Historical Low0.9200Avg Price1Lot Size
Market Insights
Discussing
Trade war escalates: What’s next for Chinese stocks?
🎙️Discussion 1. China-EU EV negotiations kick off recently. How do you think the negotiations will impact the performance of related stocks
Moo Earnings
Feb 17 19:21
Alibaba Q4 FY2024 Earnings Preview: Predict & Win Big! 🚀
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Unlock Now
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Unlock Now
Esperion Therapeutics Stock Forum
I will Bet Anyone If you BUY This STOCK Now You Will Make 150% Minimum By Years End, with 800% Upside
Please get your Cholesterol level checked every 6 months, it is the #1 cause of DEATH.
Why I’m Buying Esperion Therapeutics $Esperion Therapeutics (ESPR.US)$ in 2025: A Deeply Undervalued Biotech on the Edge of Profitability
Esperion Therapeutics (NASDA...
Quickly back to 1 leh.
hence so lousy.
lifesciencerepo...
Why I’m Buying Esperion Therapeutics $Esperion Therapeutics (ESPR.US)$ in 2025: A Deeply Undervalued Biotech on the Edge of Profitability
Esperion Therapeutics (NASDAQ: ESPR) looks like one of the most compelling—and misunderstood—opportunities in biotech. Despite having two FDA-approved drugs, expanding gl...
always see such braggy articles,and always after them published,the stock price is down
Esperion Therapeutics has been hammered down this year to an unrealistic valuation.
Esperion Therapeutics (ESPR) seems to be an unknown to many but is a fascinating story in the biotech world right now, particularly in the cardiovascular space. Despite its promising treatments and upcoming milestones, Esperion is currently trading at an extremely ...
Let’s be clear: Esperion Therapeutics $Esperion Therapeutics (ESPR.US)$ is not failing—its leadership is.
CEO Sheldon Koenig and CFO Ben Halladay have betrayed shareholder trust, mismanaged communications, and allowed short sellers to dominate the narrative while sitting on a goldmine of science, partnerships, and financial upside. Activists maybe ...
No comment yet